Redx Pharma Ltd
Redx Pharma Ltd
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2, Placebo-Controlled Study of Oral RXC008 for Crohn's Strictures | Constriction, Pathologic, Crohn disease, Digestive System Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07832435 | |
| Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis | Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, idiopathic pulmonary fibrosis | Active, not recruiting | Phase 2 | 2024-08-23 | NCT05570058 |